(DENVER, CO) December 15, 2010 — BAZI International, Inc. (OTC Bulletin Board: BAZI) announced today the appointment of Debbie Wildrick as the company’s Executive Vice President of Sales and Marketing. In her new role, Wildrick will oversee the brand’s global sales growth and brand direction, reporting directly to the company’s CEO, Kevin Sherman.
“Debbie is regarded as the foremost beverage channel strategy expert in North America- she has built a reputation as a game changer,” said Sherman. “Her proven track record will have an immediate effect on BAZI’s short-and long-term growth. We’re confident she will hit the ground running and help bring this explosive brand to its full potential in all of our core sales channels.”
BAZI emerged in August 2010 as a healthy alternative to dangerous energy beverages with its sustainable “energy for life” formula. The 2-ounce shot is packed with eight superfruits, providing both substantial nutritional benefits and a natural boost in energy. BAZI has already secured the interest of several major national retailers and will be seen on shelves throughout North America in 2011.
“At a time when the energy beverage market has been under fire, I can speak confidently in my belief in the BAZI brand as a vital, healthy alternative with tremendous potential,” said Wildrick.
“The company has a great deal of momentum and is clearly investing in its future. I’m primed to bring this brand to market and help set a new paradigm in the shot category.”
Wildrick brings 30 years of beverage experience to BAZI with her former leadership roles at Fortune 500 companies including 7-Eleven, Inc. and Tropicana North America (Pepsico). Her leadership roles include a strong background in building start-up brands including FRS Healthy Energy and Sundance Juice Sparklers (known today as IZZE), a brand which she helped grow to 100 million dollars in the early 1990s. She has also worked with leading companies in the industry to include The McLane Company, Exxon/Mobil, Target, GNC, Rite Aid, Safeway, Wyndham Hotels and many others. Before joining BAZI, Wildrick built a successful consulting business dedicated to helping new and emerging brands maximize their potential by driving sales and profitability.
In addition to her robust career, Wildrick has served as the education chair of the Network of Executive Women for more than six years. She is a regular panelist, speaker and columnist for BevNet, the leading beverage-oriented media company, producing a web site, print magazine and live conference series. Wildrick was president of the Association of Women Executives in 2003 and 2004 and is a graduate of the Cornell Food Executive Program.
Bazi International, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. Its primary product is BAZI®, a healthy, concentrated, energy shot with eight super fruits, including jujube, acai, mangosteen, goji, pomegranate, blueberry, raspberry and seabuckthorn, plus a variety of phytonutrients, antioxidants, vitamins and trace minerals, supporting the critical nutrition needed daily in a convenient, great tasting 2 ounce shot. BAZI's commitment to quality, science and research has earned the company a loyal following of world-class athletes and an elite list of endorsers, including Olympic athletes. For more information about BAZI®, please visit www.drinkbazi.com.
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “if”, “should” and “will” and similar expressions as they relate to BAZI International, Inc. are intended to identify such forward-looking statements. BAZI International, Inc. may from time to time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see “Risk Factors” in BAZI’s report on Form 10-K filed with the Securities and Exchange Commission and its other filings under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.